Dishman Carbogen Amcis’ arm completes Swissmedic inspection of Vionnaz facility

10 Jan 2025 Evaluate

Dishman Carbogen Amcis’ wholly owned subsidiary -- CARBOGEN AMCIS AG has successfully completed a Swissmedic inspection of its Vionnaz facility, reaffirming the site’s compliance with high regulatory standards. Swissmedic, the Swiss Agency for Therapeutic Products, conducted a routine two-day inspection at the company’s Vionnaz site in Switzerland from November 13, 2024 to November 14, 2024. 

Led by an inspector from the Regional Medicines Inspectorate of Western Switzerland (ISOPTh), the inspection focused on the Quality Management System compliance for the development and manufacture of highly potent APIs, including analytical and quality control processes. The site’s GMP Certification has been successfully renewed. 

This continues a series of successful inspections in Vionnaz, starting with the first in 2015 and followed by subsequent inspections in 2016, 2017, 2020, and 2022. It reinforces CARBOGEN AMCIS’s strong history of compliance with Swissmedic requirements.

Dishman Carbogen Amcis (DCAL), incorporated in 1983, started out as a manufacturer of quaternary ammonium and phosphate compounds. Currently, the company is a fully integrated CRAMS player working with global pharmaceutical innovators.


Dishman Carbogen Amc Share Price

223.15 -5.45 (-2.38%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×